Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 51 | 59 | +8 |
| Shares | 5.26M | 5.93M | +672.2K (+12.8%) |
| Value | $15.4M | $15.2M | −$115.1K (−0.7%) |
New holders (10)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 19,457 | $50.0K | 0.00% |
| Atria Investments LLC | 16,611 | $42.7K | 0.00% |
| XTX Topco Ltd | 15,474 | $39.8K | 0.00% |
| Oxford Asset Management LLP | 10,072 | $25.9K | 0.03% |
| Royal Bank of Canada | 5,081 | $13.0K | 0.00% |
| Compagnie Lombard Odier SCmA | 875 | $2.25K | 0.00% |
| Russell Investments Group, Ltd. | 250 | $643 | 0.00% |
| Mather Group, LLC. | 100 | $292 | 0.00% |
| Innealta Capital, LLC | 13 | $33 | 0.00% |
| Simplex Trading, LLC | 75 | $0 | 0.00% |
Sold out (2)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Newbridge Financial Services Group, Inc. | 657 | $1.92K |
| Tyler-Stone Wealth Management | 300 | $876 |